Apr 04, 2019 / 12:30PM GMT
Operator
Welcome to the conference call hosted by Daré Bioscience to provide financial results for the quarter ended December 31, 2018, and a general business update. This call is being recorded. My name is Chris, and I will be your operator today.
With us today are Sabrina Martucci Johnson, Daré's Chief Executive Officer; Lisa Walters-Hoffert, Daré's Chief Financial Officer; and John Fair, Daré's Chief Business Officer. Ms. Johnson, please proceed.
Sabrina Martucci Johnson - DaréBioscience - Inc. - President, CEO, Secretary & Director
Thank you. Welcome to our financial results and business update call for Daré Bioscience. It's a pleasure to have the opportunity to talk about our 2018 results, our company highlights and upcoming milestones for 2019 and 2020.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Q4 2018 Dare Bioscience Inc Earnings Call Transcript
Apr 04, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers